Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06734520
NA

Clinical Study of Super Transplantation in the Treatment of Severe β-thalassemia

Sponsor: Guangzhou Women and Children's Medical Center

View on ClinicalTrials.gov

Summary

This is a single-arm, open label, phase 1 study in subjects with beta-thalassemia. This study will evaluate the safety and efficacy of preconditioning-free super-transplantation on beta-thalassemia pediatric patients.

Key Details

Gender

All

Age Range

7 Years - 10 Years

Study Type

INTERVENTIONAL

Enrollment

3

Start Date

2024-10-01

Completion Date

2029-07-01

Last Updated

2024-12-16

Healthy Volunteers

No

Interventions

DRUG

super-transplantation in 3 severe β -thalassemia pediatric patients.

Haplo-identical donors are mobilized with G-CSF and PBMCs that contain CD34+ stem cells and CD3+ lymphocytes will be extracted by blood cell separators. Then the patients will be infused with the PBMC

Locations (2)

Guangzhou Women and Children's Medical Center Affiliated to Guangzhou Medical University

Guangzhou, Guangdong, China

Guangzhou Women and Children's Medical Center Affiliated to Guangzhou Medical University

Guangzhou, Guangdong, China